TORONTO, Aug. 4, 2022
/CNW/ - DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) ("DRI" or
"the Trust") today announced that the Trust will participate in the
following investor conferences in August and September:
Canaccord Genuity Annual Growth
Conference
Date: August 10, 2022
Presentation time: 9:00 am ET
City: Boston, Massachusetts
Event URL:
https://www.canaccordgenuity.com/capital-markets/about-us/events/42nd-annual-growth-conference/
CIBC Eastern Institutional
Investor Conference
Date: September 21, 2022
Presentation time: TBD
City: Montreal, Quebec
About DRI Healthcare
Trust
DRI Healthcare Trust provides unitholders with differentiated
exposure to the anticipated growth in the global pharmaceuticals
and biotechnology markets. Our business model is focused on
managing and growing a diversified portfolio of pharmaceutical
royalties with the aim to deliver attractive growth in cash royalty
receipts over the long-term. DRI Healthcare Trust is an
unincorporated open-ended trust governed by the laws of the
Province of Ontario, externally
managed by its manager, DRI Capital Inc., a pioneer in global
pharmaceutical royalty monetization. Throughout its history, DRI
Capital has provided capital to biopharma innovators, including
inventors, institutions, and biopharma companies, building a
diversified portfolio of interests in medicines that have a
demonstrable positive impact on the world, acquiring dependable,
patent-protected cash flow streams derived from the sales of those
important drugs. Active across a broad range of therapeutic areas,
DRI Capital has deployed more than $2
billion, acquiring more than 60 royalties on 40-plus drugs,
including Eylea, Spinraza, Zytiga, Remicade, Keytruda and Stelara.
DRI Healthcare Trust's units are listed and trade on the Toronto
Stock Exchange in Canadian dollars under the symbol "DHT.UN" and in
U.S. dollars under the symbol "DHT.U". To learn more visit
drihealthcaretrust.com.
SOURCE DRI Healthcare Trust